Consolidation with High-Dose Combination Alkylating Agents with Bone Marrow Transplantation Significantly Improves Disease-Free Survival in Hormone-Insensitive Metastatic Breast Cancer in Complete Remission Compared with Intensive Standard-Dose Chemotherapy Alone
Open Access
- 1 February 2006
- journal article
- research article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 12 (2) , 195-203
- https://doi.org/10.1016/j.bbmt.2005.10.009
Abstract
No abstract availableFunding Information
- National Cancer Institute
This publication has 29 references indexed in Scilit:
- Autologous hematopoietic stem cell transplantation for breast cancer in Europe: critical evaluation of data from the European Group for Blood and Marrow Transplantation (EBMT) Registry 1990–1999Bone Marrow Transplantation, 2003
- Double high-dose chemotherapy with adriamycin, paclitaxel, cyclophosphamide, and thiotepa followed by autologous peripheral blood stem cell transplantation in women with metastatic breast cancerZeitschrift für Krebsforschung und Klinische Onkologie, 2003
- Cancer Statistics, 2003CA: A Cancer Journal for Clinicians, 2003
- Phase II Multicenter Trial of a Weekly Paclitaxel and Carboplatin Regimen in Patients With Advanced Breast CancerJournal of Clinical Oncology, 2002
- Phase II trial of sequential high-dose chemotherapy with paclitaxel, melphalan and cyclophosphamide, thiotepa and carboplatin with peripheral blood progenitor support in women with responding metastatic breast cancerBone Marrow Transplantation, 2002
- Superior Survival With Capecitabine Plus Docetaxel Combination Therapy in Anthracycline-Pretreated Patients With Advanced Breast Cancer: Phase III Trial ResultsJournal of Clinical Oncology, 2002
- Tandem-cycle high-dose melphalan and cisplatin with peripheral blood progenitor cell support in patients with breast cancer and other malignanciesTransplantation and Cellular Therapy, 2001
- High-dose chemotherapy consolidation with autologous stem cell rescue in metastatic breast cancer: a 10-year experienceBone Marrow Transplantation, 1998
- The duke afm program intensive induction chemotherapy for metastatic breast cancerCancer, 1990
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958